Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

SVR & Risk of T2D Among Patients with HCV

J Viral Hepat; ePub 2018 Feb 25; Li, Zhang, et al

Among a large US cohort of patients treated for hepatitis C virus (HCV), patients who achieved sustained virological response (SVR) demonstrated a substantially lower risk for development of type 2 diabetes mellitus (T2D) than patients with treatment failure. This according to a study that examined how response to HCV treatment impacts risk of subsequent T2D. Among HCV patients without a history of T2D or hepatitis B, researchers investigated incidence of T2D from 12 weeks post-HCV-treatment through December 2015. They found:

  • Among 5,127 patients with an average follow-up of 3.7 years, T2D incidence was significantly lower among patients who achieved SVR than among patients with treatment failure (6.2% vs 21.7%).
  • Risk of T2D was higher among African American and Asian American patients vs white patients (adjusted hazard ratio [aHR], 1.82 and 1.75, respectively).
  • Patients with body mass index (BMI) ≥30 and 25-20 demonstrated higher risk than those with BMI <25.
  • Cirrhosis at baseline was also a risk factor.

Citation:

Li J, Zhang T, Gordon SC, et al. Impact of sustained virological response on risk of type 2 diabetes among hepatitis C patients in the US. [Published online ahead of print February 25, 2018]. J Viral Hepat. doi:10.1111/jvh.12887.

This Week's Must Reads

Screening for Syphilis Infection in Pregnant Women, JAMA; 2018 Sep 4; US Preventive Services Task Force

Treatment Intensification Guidelines for T2D , Ann Intern Med; ePub 2018 Sep 4; Roglic, et al

Immediate vs Gradual Nicotine Reduction in Cigarettes, JAMA; ePub 2018 Sep 4; Hatsukami, et al

Prevalence of Diabetes Among US Adults, BMJ; ePub 2018 Aug 27; Xu, Liu, et al

Effect of Fish Oil Supplementation in Pregnancy, BMJ; ePub 2018 Sep 4; Vinding, Stokholm, et al

Must Reads in Hepatitis

Treatment Uptake for HCV in VA Healthcare System, Clin Infect Dis; ePub 2018 Aug 22; Butt, et al

Prevalence of HCV Among Baby Boomers in US, J Infect Public Health; ePub 2018 Aug 28; Moore, et al

Universal Screening for Chronic HCV Infection, Clin Gastroenterol Hepatol; ePub 2018 Sep 7; Eckman, et al

Health-Related QOL in HIV/HCV Coinfected Patients, J Viral Hepat; ePub 2018 Aug 23; Saeed, et al

HCV Testing of PWID in High-Prevalence Settings, J Viral Hepat; ePub 2018 Jul 26; Scott, et al